159 related articles for article (PubMed ID: 8827069)
1. Histological analysis of aggressiveness and responsiveness in Wilms' tumor.
Beckwith JB; Zuppan CE; Browning NG; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):422-8. PubMed ID: 8827069
[TBL] [Abstract][Full Text] [Related]
2. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
3. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
[TBL] [Abstract][Full Text] [Related]
4. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
[TBL] [Abstract][Full Text] [Related]
5. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
6. Histopathological variations among cases of Wilms' tumor in Bangladesh and its relationship with prognosis.
Ara T; Khan WA; Ali SM
Bangladesh Med Res Counc Bull; 1997 Aug; 23(2):56-9. PubMed ID: 9465437
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor: past, present and (possibly) future.
Spreafico F; Bellani FF
Expert Rev Anticancer Ther; 2006 Feb; 6(2):249-58. PubMed ID: 16445377
[TBL] [Abstract][Full Text] [Related]
8. Current therapy for Wilms' tumor.
Metzger ML; Dome JS
Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
10. [New aspects of nephroblastoma (Wilms tumor) and other metanephrogenic neoplasms].
Harms D; Schmidt D; Leuschner I
Verh Dtsch Ges Pathol; 1989; 73():350-71. PubMed ID: 2482620
[TBL] [Abstract][Full Text] [Related]
11. Current challenges in Wilms' tumor management.
Gommersall LM; Arya M; Mushtaq I; Duffy P
Nat Clin Pract Oncol; 2005 Jun; 2(6):298-304; quiz 1 p following 324. PubMed ID: 16264987
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of advanced Wilms' tumor].
Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
[TBL] [Abstract][Full Text] [Related]
14. Serum hyaluronan and its association with unfavorable histology and aggressiveness of heterotransplanted Wilms' tumor.
Lovvorn HN; Savani RC; Ruchelli E; Cass DL; Adzick NS
J Pediatr Surg; 2000 Jul; 35(7):1070-8. PubMed ID: 10917299
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
[TBL] [Abstract][Full Text] [Related]
16. Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study.
Hamilton TE; Green DM; Perlman EJ; Argani P; Grundy P; Ritchey ML; Shamberger RC
J Pediatr Surg; 2006 Oct; 41(10):1641-4. PubMed ID: 17011261
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
18. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.
Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA
Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352
[TBL] [Abstract][Full Text] [Related]
19. Aspiration cytology of Wilms' tumor.
Dey P; Radhika S; Rajwanshi A; Rao KL; Khajuria A; Nijhawan R; Banarjee CK
Acta Cytol; 1993; 37(4):477-82. PubMed ID: 8392251
[TBL] [Abstract][Full Text] [Related]
20. p53 expression in Wilms' tumor: a possible role as prognostic factor.
Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G
Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]